Ciprofol
- Generic Name
- Ciprofol
- Indication
用于消化道内镜检查中的镇静、支气管镜检查中的镇静以及全身麻醉诱导。
Phase III Clinical Trial Evaluating the Efficacy and Safety of Ciprofol Injection for the Induction of Sedation/Anesthesia in Subjects Undergoing Gynecological Outpatient Surgeries
- First Posted Date
- 2021-07-12
- Last Posted Date
- 2022-06-02
- Lead Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Target Recruit Count
- 135
- Registration Number
- NCT04958746
- Locations
- 🇨🇳
Peking University First Hospital, Beijing, China
Study for Evaluating the Efficacy of Ciprofol in Patients Under Narcotic Sleep With Chronic Insomnia
- Conditions
- Chronic Insomnia
- Interventions
- Drug: medium/long chain fat emulsion injection (C8-24Ve)
- First Posted Date
- 2021-07-12
- Last Posted Date
- 2023-11-30
- Lead Sponsor
- Sichuan Provincial People's Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT04958382
- Locations
- 🇨🇳
Sichuan Provincial People's Hospital, Sichuan, China
Efficacy and Safety of HSK3486 Compared to Propofol in Induction of General Anesthesia in Adults Having Elective Surgery
- First Posted Date
- 2021-01-15
- Last Posted Date
- 2023-10-06
- Lead Sponsor
- Haisco-USA Pharmaceuticals, Inc.
- Target Recruit Count
- 255
- Registration Number
- NCT04711837
- Locations
- 🇺🇸
Lotus Clinical Research, LLC, Pasadena, California, United States
🇺🇸Phoenix Clinical Research, LLC, Tamarac, Florida, United States
🇺🇸Plano Surgical Hospital, Plano, Texas, United States
A Clinical Study Evaluating Sedation of Intravenous Administration of HSK3486 in ICU Patients Undergoing Long-Term Mechanical Ventilation
- First Posted Date
- 2020-12-17
- Last Posted Date
- 2022-05-27
- Lead Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT04669821
- Locations
- 🇨🇳
The First Affiliated Hospital of Xinjiang Medical University, Xinjiang, China
A Study Evaluating Sedation of Intravenous Administration of HSK3486 Injectable Emulsion in ICU Patients Undergoing Mechanical Ventilation
- First Posted Date
- 2020-11-06
- Last Posted Date
- 2022-05-27
- Lead Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Target Recruit Count
- 135
- Registration Number
- NCT04620031
- Locations
- 🇨🇳
The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
A Study to Evaluate the Efficacy and Safety of HSK3486 in the Induction of General Anesthesia
- Conditions
- Induction and Maintenance of General Anesthesia
- Interventions
- First Posted Date
- 2020-08-13
- Last Posted Date
- 2022-05-31
- Lead Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Target Recruit Count
- 129
- Registration Number
- NCT04511728
- Locations
- 🇨🇳
West China Hospital，Sichuan University, Chengdu, China
A Study to Evaluate the Differences in Pharmadynamics, Pharmacokinetics, and Safety Between Ciprofol and Propofol
- First Posted Date
- 2020-03-03
- Last Posted Date
- 2020-11-20
- Lead Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Target Recruit Count
- 18
- Registration Number
- NCT04294056
- Locations
- 🇨🇳
Sichuan Provincial People's Hospital, Chengdu, China
Safety and Pharmacokinetics/Pharmacodynamics of HSK3486 in Healthy Elderly Subjects
- First Posted Date
- 2019-12-13
- Last Posted Date
- 2020-12-17
- Lead Sponsor
- Sichuan Haisco Pharmaceutical Group Co., Ltd
- Target Recruit Count
- 32
- Registration Number
- NCT04197661
- Locations
- 🇨🇳
Phase I Clinical Trial Laboratory, The First Hospital of Jilin University, Chang chun, Ji Lin, China
A Study Evaluating Drug-Drug Interaction (DDI) Between HSK3486 Injectable Emulsion and Voriconazole Tablets
- First Posted Date
- 2019-10-30
- Last Posted Date
- 2020-12-19
- Lead Sponsor
- Sichuan Haisco Pharmaceutical Group Co., Ltd
- Target Recruit Count
- 16
- Registration Number
- NCT04145583
- Locations
- 🇨🇳
the First Affilicated Hospital of Soochow University, Suzhou, China
Safety and Pharmacokinetics/Pharmacodynamics of HSK3486 in Patients With Hepatic Impairment
- First Posted Date
- 2019-10-30
- Last Posted Date
- 2020-12-17
- Lead Sponsor
- Sichuan Haisco Pharmaceutical Group Co., Ltd
- Target Recruit Count
- 24
- Registration Number
- NCT04145596
- Locations
- 🇨🇳
Phase I Clinical Trial Laboratory, The First Hospital of Jilin University, Chang chun, Ji Lin, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.